Progressive Institute
2 Trap Falls Road, Suite 120, Shelton, CT 06484
Progressive Institute is an intensive outpatient and outpatient facility in Shelton, CT offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, TRICARE, Medicaid, and private insurance.
Licenses and accreditations
- State department of healthLicensed by the state's department of health.
- The Joint CommissionAccredited by The Joint Commission.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Intensive outpatient treatment
- Several hours of treatment a day, several days a week, while living at home.
- Outpatient
- Regular appointments while living at home.
- Outpatient methadone/buprenorphine or naltrexone treatment
- Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
- Regular outpatient treatment
- Weekly or less frequent appointments while living at home.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Buprenorphine maintenance
- Buprenorphine continued over time to prevent relapse.
- Lofexidine or Clonidine detoxification
- Lofexidine or clonidine to ease withdrawal during detox.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
- Relapse prevention with naltrexone
- Naltrexone to help prevent relapse.
Payment
- Accepted
- Cash or self-payment; TRICARE and other federal military insurance; Medicaid; Private health insurance; A state-financed health insurance plan other than Medicaid.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Programs for
- Clients with co-occurring mental and substance use disorders.
More details this facility reports
- Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity; Other contracted prescribing entity.
- Pharmacotherapies
- Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Clonidine; Disulfiram; Medication for mental disorders; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement.
- Treatment Approaches
- Anger management; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling.
- Facility Operation (e.g., Private, Public)
- Private for-profit organization.
- Assessment/Pre-treatment
- Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
- Testing
- Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
- Transitional Services
- Aftercare/continuing care; Discharge Planning; Naloxone and overdose education.
- Recovery Support Services
- Assistance with obtaining social services; Mentoring/peer support; Recovery coach.
- Other Services
- Treatment for other addiction disorder.
- Education and Counseling Services
- Family counseling; Group counseling; Individual counseling; Marital/couples counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping permitted in designated area.
- Ancillary Services
- Case management service; Mental health services; Social skills development; Suicide prevention services.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.